Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-07-014216
Filing Date
2007-03-23
Accepted
2007-03-22 21:42:54
Documents
6

Document Format Files

Seq Description Document Type Size
1 v069141_f3.htm F-3 418234
2 GRAPHIC xtlbio.jpg GRAPHIC 4829
3 v069141_ex23-2.htm EX-23.2 3319
4 GRAPHIC pricelogo.jpg GRAPHIC 11093
5 GRAPHIC pricesig.jpg GRAPHIC 7836
6 v069141_ex23-3.htm EX-23.3 11785
  Complete submission text file 0001144204-07-014216.txt   467769
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: F-3 | Act: 33 | File No.: 333-141529 | Film No.: 07713313
SIC: 2834 Pharmaceutical Preparations